Sorry, but no relevant information or results could be found for your search.
The term appears to be random or without any apparent meaning. Please refine your search or browse through the latest news.
qz
Can MRK's Ongoing M&A Push Aid Long-Term Growth Ahead of Keytruda LOE?
Merck's recent M&A spree, including its $6.7B Terns deal, aims to diversify its pipeline and revenue base as Keytruda nears its 2028 exclusivity loss. [...]